Most recently, it has been determined that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in identical locations as classical opioid receptors, it binds to a wide array of endogenous opioids. As opposed to most opioid receptors, this receptor functions being a scavenger https://salvadorh653ppg2.iyublog.com/profile